internal GlcUA(b1→4)GlcNS linkages in HS, with net retention of anomeric configuration 8 . HPSE-mediated breakdown of HS is not indiscriminate but instead is restricted to a small subset of GlcUAs, thus reflecting a requirement for specific N-and O-sulfation patterns on neighboring sugars [9] [10] [11] . HPSE present in late endosomes and lysosomes performs an essential housekeeping role in catabolic processing of internalized HSPGs 12 . In addition, HPSE can be trafficked to the cell surface or released into the ECM, where it effects breakdown of extracellular pools of HS 13 .
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HPSE-mediated breakdown of HS in the ECM has several effects on the behavior of nearby cells. Weakening of structural HS networks in the ECM and basement membranes directly facilitates cell motility and extravasation into surrounding tissues 14 . Latent pools of growth factors stored by HS are released upon breakdown by HPSE and subsequently promote increased cell proliferation, motility and angiogenesis 15, 16 . HS fragments generated by HPSE activity can also activate downstream signaling cascades 17 . Whereas controlled HPSE activity plays an important part in physiological processing of the ECM, aberrant HPSE expression is associated with inflammation and cancerous growth. The proliferative advantages conferred by HPSE lead to its upregulation in tumors in a variety of tissues, and HPSE overexpression correlates strongly with metastasis and worsened clinical prognoses [18] [19] [20] [21] .
Only one gene with heparanase-like catalytic activity has been identified in mammals to date, thus suggesting that loss of HPSE activity may not easily be compensated for by the cell. Accordingly, HPSE inhibition has attracted intense interest as an anticancer strategy, although the efficacy of small-molecule inhibitors 22, 23 has yet to rival those reported for oligosaccharide-like HS mimetics [24] [25] [26] , such as the sulfated phosphomannopentaose derivative PI-88 (which is currently in phase III clinical trials as an adjuvant therapy for the treatment of HS is a sulfated glycosaminoglycan (GAG) polysaccharide produced by nearly all animal species 1, 2 . Structurally, HS is composed of a linear repeating [d-HexUA(b1→4)d-GlcNX(a1→4)] n disaccharide motif, in which HexUA is either glucuronic acid (GlcUA) or its C5 epimer, iduronic acid (IdoUA), and GlcNX is N-acetylglucosamine (GlcNAc) or N-sulfoglucosamine (GlcNS). These chains are further modified by O-sulfation at O2 of HexUA, O6 of GlcNX and (rarely) O3 of GlcNX. The deacetylation, sulfation and epimerization reactions involved in biosynthesis of HS are nontemplated and do not reach completion, thus resulting in substantial structural heterogeneity along chains. Mature HS is modular in composition, containing both 'NS' domains rich in GlcNS, IdoUA and O-sulfated sugars and separate 'NA' domains rich in GlcNAc and GlcUA but having lower O-sulfation ( Supplementary  Fig. 1 ). This heterogeneity of HS structure provides interaction sites for a large number of different binding partners and is central to the proper biological function of HS 3 .
HS occurs in vivo in the form of heparan sulfate proteoglycans (HSPGs), which consist of one or more HS chains covalently linked to a core transmembrane or secreted protein. HSPGs are an important constituent of the ECM, which surrounds cells, and they perform important structural and signaling functions via HS-mediated interactions 4 . The compositions of HS chains are adapted to their function and can differ between cells and tissues even when the core HSPG protein is the same. HS chains are also dynamically regulated in response to external stimuli: turnover in some cells occurs with a half-life as rapid as 2.5 h (refs. 5,6) . This turnover is underpinned by a network of enzymes that serve to efficiently synthesize and break down HS in a regulated fashion.
The principal enzyme involved in breakdown of HS is HPSE, a member of the carbohydrate-active enzyme (CAZy) GH79 family of carbohydrate-processing enzymes 7 . HPSE catalyzes hydrolysis of Structural characterization of human heparanase reveals insights into substrate recognition
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Heparan sulfate (HS) is a glycosaminoglycan that forms a key component of the extracellular matrix (ECM). Breakdown of HS is carried out by heparanase (HPSE), an endo-β-glucuronidase of the glycoside hydrolase 79 (GH79) family. Overexpression of HPSE results in breakdown of extracellular HS and release of stored growth factors and hence is strongly linked to cancer metastasis. Here we present crystal structures of human HPSE at 1.6-Å to 1.9-Å resolution that reveal how an endoacting binding cleft is exposed by proteolytic activation of latent proHPSE. We used oligosaccharide complexes to map the substrate-binding and sulfate-recognition motifs. These data shed light on the structure and interactions of a key enzyme involved in ECM maintenance and provide a starting point for the design of HPSE inhibitors for use as biochemical tools and anticancer therapeutics.
(out of 457) and 2.59 Å over 387 residues for AcaGH79 and BpHPSE, respectively ( Supplementary Fig. 2a ).
HPSE contains six putative N-glycosylation sites, all residing on the 50-kDa subunit. N-linked GlcNAc residues (corresponding to N-glycan trees treated by endoglycosidase H during protein preparation) were present in the apo-HPSE structure at Asn162, Asn200, Asn217, Asn238 and Asn459. Additionally we observed a core a1→6-linked fucose on the GlcNAc linked to Asn459. We found no noticeable density corresponding to GlcNAc at the N-glycosylation site Asn178, thus suggesting that this position may not be well N-glycosylated during baculoviral expression or that N-GlcNAc in this position is not compatible with crystal packing.
The GH79 family belongs to the larger GH-A clan, which is characterized by a (b/a) 8 domain containing the catalytic site 7 . We clearly observed a cleft spanning ~10 Å in the (b/a) 8 domain of apo-HPSE, thus suggesting that the HS-binding site is contained within this part of the enzyme (Fig. 1c) . This cleft contained residues Glu343 and Glu225, which have been previously identified as the catalytic nucleophile and acid-base of HPSE 31 and are required for the retaining catalytic mechanism 32 . In accordance with the negatively charged nature of its HS substrate, the HPSE binding cleft is lined by basic side chains contributed by Arg35, Lys158, Lys159, Lys161, Lys231, Arg272, Arg273 and Arg303.
The positioning of the 8-kDa-subunit C terminus and 50-kDasubunit N terminus in our model indicates that the excised Ser110-Gln157 linker of proHPSE should lie very near or even within the active site cleft of the (b/a) 8 domain. This positioning would hinder incoming HS substrates and is consistent with a previously proposed steric-block mechanism for proHPSE inactivation by its own linker 33 .
Structural basis of HPSE-substrate interactions
Interaction of HS with HPSE is influenced by substrate sulfation, and only HS sequences with particular sulfation patterns are hydrolyzed. viral hepatitis-related hepatocellular carcinomas).
Despite intense biological and clinical interest, no threedimensional (3D) structure has been reported for human HPSE. Structures of a GH79 exoglucuronidase from Acidobaterium capsulatum (AcaGH79) and, recently, of an endo-acting heparanase from Burkholderia pseudomallei (BpHPSE) have helped provide a structural overview for this enzyme family 27, 28 . To understand the mechanistic basis of HPSE function, we determined the crystal structures of human HPSE in apo and ligand-bound states. These data shed light on the structure and function of a key enzyme involved in human HS metabolism and may be of substantial utility in future efforts to rationally design inhibitors of HPSE.
RESULTS
Tertiary structure of HPSE HPSE is initially translated as a preproenzyme containing a signal sequence spanning Met1-Ala35. Cleavage of this signal sequence by signal peptidase leaves an inactive 65-kDa proHPSE, which must undergo further processing for activity. Proteolytic removal by cathepsin L of a linker spanning Ser110-Gln157 liberates an N-terminal 8-kDa subunit and a C-terminal 50-kDa subunit, which remain associated as a noncovalent heterodimer in mature active HPSE 29 . For our studies, we expressed HPSE through a baculovirus system, using a previously described dual-expression strategy 30 . We placed cDNA encoding the 8-kDa and 50-kDa subunits into a single bacmid under the control of separate viral promoters. The two subunits cotranslationally fold into mature heterodimeric HPSE, thereby bypassing the 65-kDa proenzyme form and ensuring expression of only active enzyme (Fig. 1a) .
The structure of apo-HPSE, refined to 1.75-Å resolution ( Table  1) , contains a single heterodimer in the asymmetric unit, comprising residues Gln36-Glu109 of the 8-kDa subunit and Lys159-Ile543 of the 50-kDa subunit (according to numbering based on the full preproenzyme). The domain architecture of HPSE comprises a (b/a) 8 domain flanked by a smaller b-sandwich domain. Both 8-kDa-and 50-kDa subunits are structurally involved in both domains: the 8-kDa subunit contributes one b-sheet to the b-sandwich and the first b-a-b fold of the (b/a) 8 domain, and the remaining folds are contributed by the 50-kDa subunit (Fig. 1b) . Overall, the domain architecture of HPSE is superficially similar to that of previously characterized bacterial GH79s 27,28 , with Ca r.m.s. differences of 2.35 Å over 392 residues Asn224 and Tyr391 as well as to the backbone NHs of Thr97, Gly349 and Gly350. A strong network of hydrogen bonds from the GlcUA C6 carboxylate to Tyr391, Gly349 and Gly350 was similar to that observed in the bacterial GH79s, thus suggesting the conservation of a key GH79 motif that has been tuned to recognize GlcUA. Our structures also showed that the presence of GlcUA(2S) or IdoUA(2S) at the -1 subsite cannot be tolerated by HPSE, owing to steric clashes between the bulky 2O-sulfate and Asn224.
GlcNX residues at the -2 subsite also adopt a 4 C 1 conformation in all complexes and illustrate HPSE's ability to accommodate a variety of GlcNX sugars at this position. Surprisingly, only the N2 position of GlcNX appeared to make any direct hydrogen-bonding interactions to HPSE: for both GlcNAc and GlcNS, the amide NH formed a hydrogen bond to the side chain of Tyr391. For GlcNAc, the amide carbonyl formed a hydrogen bond to both Asn64 and a structural water molecule, whereas GlcNS made these same interactions as well as hydrogen bonds to a further structural water and the backbone NH of Gly389. For -2 GlcNS(6S), 6O-sulfate was ideally placed to participate in electrostatic interactions with the side chain of Lys159. Hence, GlcNS(6S) at the -2 subsite should be favored over GlcNS, which is favored over GlcNAc, because of the formation of additional electrostatic and hydrogen-bonding interactions, respectively.
Lack of density at the +1 subsite for M09 S05a, in contrast to that for M04 S00a and M04 S02a, suggested that the observed structure reflected several related complexes differing at this position. Inspection of GlcNS(6S) at the -2 subsite also revealed that the electron density for 6O-sulfate was considerably weaker than that for N-sulfate ( Supplementary Fig. 2b) , thus indicating that this Studies using defined HS oligomers have suggested that HPSE preferentially cleaves a trisaccharide with sulfated GlcNX residues at the -2 and +1 positions 9, 10, 34, 35 (subsite nomenclature in ref. 36 ). However, a mechanistic understanding of how HPSE 'reads' the sulfation status of HS substrates and selects favorable cleavage sites has so far been lacking.
We mapped the substrate-binding and sulfate-interaction sites of HPSE by obtaining structures of the enzyme in complex with a set of HS analogs. We initially chose three 'HepMers' , semisynthetic HS oligomers of defined structure 34 , to investigate the effect of systematically increasing N-and O-sulfation: M04 S00a (a tetrasaccharide with no sulfation), M04 S02a (a tetrasaccharide with only N-sulfation) and M09 S05a (a nonasaccharide with N-sulfation and a single GlcNS(6S) toward the reducing end) ( Fig. 2a) .
Complexes of HPSE with the three HepMers showed clear electron density for the ligands within the active site cleft, thus revealing the basis of interaction at the -1 and -2 binding subsites ( Fig. 2b-d) . The electron density was progressively more disordered from the -3 sugar onward as the substrate exited the binding cleft, in accordance with HPSE recognizing a trisaccharide spanning the -2, -1 and +1 subsites. For M04 S00a and MO4 S02a, the electron density for the reducingend paranitrophenol (pNP) moiety was clearly visible at the +1-equivalent position, thus suggesting that these molecules are poor substrates for HPSE. In contrast, density at +1 for M09 S05a was almost absent.
Binding of GlcUA at the -1 subsite was identical in all HepMer complexes, in which the ring was in 4 C 1 conformation, and the anomeric carbon was close to the nucleophile Glu343. We observed direct hydrogen bonds to HPSE from GlcUA to the side chains of Asp62, was better modeled by a molecule containing IdoUA at -1 (instead of IdoUA(2S)), thus confirming that 2O-sulfate at the -1 subsite is not tolerated. The electron density for dp4 in HPSE was correspondingly weaker than for HepMers across all subsites, a result reflecting the binding of a minor constituent. The overall configuration of dp4 across the HPSE active site was similar to that of HepMers, but -1 IdoUA adopted a 2 S O conformation instead of the 4 C 1 conformation seen for GlcUA in HepMers. In free heparin, IdoUA residues exist in an easily traversable equilibrium between 1 C 4 and 2 S O , with the O2 position held axial or equatorial, respectively 39 . Upon binding to HPSE, hydrogen-bonding to Asn224 and the presence of clashing Glu343 at the O2 axial position constrain -1 IdoUA to the 2 S O conformation. IdoUA constrained in 2 S O may be hindered from undergoing the conformational changes required for hydrolysis 40 , thus perhaps explaining why heparin-type ligands containing IdoUA residues act as competitive inhibitors of HS cleavage.
Some density at the +1 subsite, although weak, was resolved in the dp4 complex, thus suggesting the presence of +1 6O-sulfate, which we tentatively modeled as GlcNS(6S). In our model, GlcNS(6S) at the +1 subsite adopts an undistorted 4 C 1 conformation, in which 6O-sulfate provides the main interactions to HPSE via hydrogen bonds to the backbone and side chain NH of Gln270, as well as electrostatic interactions with Arg272. According to its positioning in our model, further electrostatic interactions may also exist between +1 N-sulfate and Arg303, although we were unable to confirm this, given the poor density for the ligand at this position. Although dp4 contains IdoUA instead of GlcUA at the -1 subsite, both GlcUA 4 C 1 and IdoUA 2 S O conformations involve a similar all-equatorial arrangement of substituents around the sugar ring. Therefore, we propose that the position subsite was probably occupied by a mixture of GlcNS and GlcNS(6S). Although M09 S05a contains several GlcNS residues, binding of HPSE far toward the reducing end of M09 S05a is strongly disfavored in crystallo, owing to the presence of a clashing symmetry molecule at the 'positive' end of the binding cleft (Supplementary Fig. 2c ). Hence, we concluded that the M09 S05a complex reflected partial HPSE binding only one disaccharide unit further from the reducing end. This would imply GlcNS(6S) occupancy of the +1 subsite or alternatively a product complex in which a +1 GlcNS(6S) had been hydrolyzed. We were thus able to determine kinetic parameters for HPSE hydrolysis of M09 S05a through a colorimetric reducing-end assay (K m = 7.70 ± 1.42 µM, k cat = 0.53 ± 0.02 s -1 (mean ± s.e.m.); Supplementary Fig. 3) but not for M04 S00a or M04 S02a. Whereas K m for M09 S05a hydrolysis was in the low-micromolar range, comparably to previously reported HPSE activity (1.64 mM for natural HS 37 and 46 mM for the synthetic substrate fondaparinux 38 ), k cat for M09 S05a was ~15% of that previously determined for fondaparinux (3.5 s -1 ), possibly reflecting differences in substrate sulfation or oligosaccharide length.
Because +1-subsite interactions were not resolvable through HepMers, we sought to obtain a structure of HPSE in complex with a heparin-derived tetrasaccharide (hereafter dp4, generated by depolymerization of full-length heparin by heparin lyases; Fig. 2a) . Like HS and heparin itself, dp4 is a mixture of structurally related disaccharide units, with the tetrasaccharide DHexUA(2S)-GlcNS(6S)-IdoUA(2S)-GlcNS(6S) as the major component. The structure of HPSE with dp4 showed occupancy of the same binding site as for HepMers ( Fig. 2e) , consistently with the overall similarity of heparin to HS. The observed density was not, however, for the predominant dp4 tetrasaccharide but
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Asp62 Tyr391 biochemical studies on the HS sulfation patterns required for HPSE cleavage [9] [10] [11] . We confirmed that sulfation is key for HPSE interaction with HS and that the recognized cleavage site is a trisaccharide accommodated in the HPSE binding cleft. Structurally, -2 N-sulfate and +1 6O-sulfate appear to be the main determinants for recognition, because these directly contact the enzyme through hydrogen-bonding networks. -2 6O-sulfate and +1 N-sulfate may also further stabilize the HPSE-bound trisaccharide through electrostatic interactions to basic residues lining the active site cleft. Our observations are consistent with the major findings of previous biochemical studies.
Whereas the activity of human HPSE (hHPSE) is broadly similar to that of the recently reported bacterial enzyme BpHPSE 28 , differences exist between the substrates hydrolyzed by each enzyme. BpHPSE has been reported to preferentially cleave HS-containing GlcNAc residues, whereas GlcNS is highly favored by hHPSE. Furthermore, BpHPSE has also been found to degrade chondroitin sulfate GAGs, which are not known to be a substrate for hHPSE. Sequence alignment of several eukaryotic heparanases with BpHPSE and AcaGH79 revealed that whereas residues at the -1 subsite (of hHPSE) are well conserved across all species (thus reflecting absolute specificity for GlcUA), residues at the -2 and +1 subsites show much poorer conservation in the bacterial enzymes, thus providing a rationale for observed differences in substrate specificity (Supplementary Fig. 4 ). Compared to hHPSE, BpHPSE may represent a more general catabolic enzyme that is used by the bacterium to break down GAGs encountered in its environment.
One point of particular interest is the evolutionary relationship between exo-and endo-acting GH79 enzymes, especially regarding the nature of the loop that forms part of the exo-acting substrate-binding pocket in AcaGH79 (Fig. 4b and Supplementary  Fig. 5) . In comparison to that in AcaGH79, this loop is substantially reduced in size in endo-acting BpHPSE, thus converting the binding pocket into a large cleft capable of accommodating long GAG chains. In contrast, the human enzyme appears to have evolved endo specificity though expansion of this loop into a proteolytically cleavable linker motif. Proteolytically activated proenzymes are abundant in higher eukaryotes and represent an efficient mechanism to induce enzymatic activity in response to stimuli. However, de novo evolution of proenzymes is extremely unlikely, because it would require the coevolution of both viable enzymatic and proteolyzable sequences. A more plausible scenario involves expansion of a small loop around the active site of an existing enzyme scaffold; the loop would eventually form a larger proteolytically cleavable steric block that could be removed for activation. This mechanism has already been hypothesized for serine proteases such of GlcNS(6S) at the +1 subsite is also likely to be relevant for an HS substrate containing GlcUA instead of IdoUA.
HPSE interaction induces distortion of the substrate chain
The structure of free heparin has been extensively studied; it adopts a linear right-handed helix with a rotation of ~180° and translation of 0.82-0.87 nm per disaccharide unit [41] [42] [43] . Sulfates are presented in clusters on the surface of the sugar chain, and their distribution reflects whether IdoUA residues are in the 1 C 4 or 2 S O conformation. The helical heparin conformation is retained in complex with binding partners, as seen in crystal structures of heparin bound to fibroblast growth factor or antithrombin [44] [45] [46] , which also illustrate the role of sulfation in mediating electrostatic interactions with basic residues on heparin-interacting proteins. In contrast, the presence of a bulky negatively charged 'coat' surrounding the core glycan may hinder access to nucleophilic protein residues, thereby protecting the sugar residues from enzymatic attack.
Dp4 in complex with HPSE retains an approximately right-handed helical configuration within the active site cleft, similarly to free heparin. However, interactions from HPSE to -2 N-sulfate and +1 6O-sulfate introduce a clear bend in the heparin chain across the -2, -1, +1 trisaccharide. In comparison to a previous model for an idealized heparin helix 42 , the distance between -2(N2) and -1(O2) for dp4 in HPSE increased from 4.8 Å to 7.2 Å, and the distance between -1(O2) and +1(C6) increased from 4.4 Å to 5.7 Å (Fig. 3a,b) . This 'bend' separates the N2 and O6 sulfates adjacent to the -1 anomeric center and hence allows the catalytic residues of HPSE to access this position more easily. Although we did not observe a +1-subsite sugar in HepMer-HPSE complexes, we found a similar distortion for HepMers across the -2 and -1 subsites (lengthened distance between -2(N2) and -1(O2) of 7.1 Å for M09 S05a ; Fig. 3c) . These results suggest that the 'bending' observed for dp4 is also likely to apply to substrates with a -1 GlcUA instead of IdoUA.
Our results indicate a dual role for HS sulfation in interactions with HPSE. Not only does sulfation serve as a molecular signal that directs the enzyme to cleave only certain glycan sites, but -2 N-sulfate and +1 O-sulfate moieties also act as mechanistic handles by which HPSE can prize open a substrate HS helix and more effectively access the anomeric center of the -1 sugar.
DISCUSSION
The 3D structure of the human GH79 endoglucuronidase HPSE and its interaction with HS substrates (Fig. 4a) provides a long-anticipated structural rationale that ties together the results of numerous M.B.) ).
as the trypsinogen-trypsin and chymotrypsinogen-chymotrypsin proenzyme-enzyme pairs 47 . Structural observations on HPSE and related enzymes have provided evidence that such evolutionary processes may have also occurred for carbohydrate-processing enzymes. We anticipate that further examples of such relationships will become apparent in the near future, as efforts to solve the structures of higher eukaryotic carbohydrate processing enzymes intensify.
In conclusion, our structures of HPSE and its ligand complexes provide insight into the mechanisms of action of a key player in ECM remodeling. The structures reported here should be of utility in future efforts to design improved inhibitors of HPSE for use as therapeutics and/or chemical biology tools. Indeed, our complex of HPSE with the tetrasaccharide dp4 already suggests that introduction of sugars at the -1 subsite, fixed in particular conformations, may be a viable strategy for inhibitor design. More fundamentally, GAGs such as HS have important roles in numerous biological processes, both normal and pathological. An understanding of the enzymes involved in GAG processing will be essential for determining how this important and complex class of carbohydrates is regulated. In contrast, hHPSE has expanded this loop into a large linker sequence, which is proteolytically removed to produce its endo-acting binding cleft.
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